How to choose a CBD dosage – drops, mg, effects – guide 2026
How to choose a CBD dose in 2026: start from 25 mg, RCT 300 mg for anxiety (Linares 2019), sublingual bioavailability 13-19%, mg/drop per concentration 5-30%.
How to choose a CBD dose that works, rather than just lighting up your wallet? The most common mistake is counting drops instead of milligrams and skipping the titration stage. A starting point for adults is usually 20-25 mg per day. This is the dose used by Shannon in the retrospective series in the Permanente Journal in 2019, where 79.2% of patients reported reduced anxiety, and 66.7% improved sleep (Shannon, Permanente Journal, 2019).
This guide explains the math of dosing, bioavailability by route of administration, and the start low go slow protocol. You will see mg/drop tables for concentrations of 5%, 10%, 15%, 20%, and 30%. You will check how CBD was dosed in Linares' randomized study on anxiety (300 mg) and what the bell-shaped curve described by Gallily and Mechoulam in 2015 means.
We also talk about traps. Why "more" does not mean "better". Why dosing based on body weight at 1 mg/kg is a simplification, not a rule. How to interpret data from the FDA Epidiolex, where children with epilepsy receive 20 mg/kg/day. After reading, you will know how to create a two-week dosing plan that does not waste product.
Key findings
– Start low go slow: start with 20-25 mg of CBD daily and increase by 5-10 mg every 5-7 days until you find the minimum effective dose (Project CBD, 2023).
– Mg/drop per concentration: 5% is 1.67 mg, 10% is 3.33 mg, 15% is 5 mg, 20% is 6.67 mg, 30% is 10 mg/drop with 30 drops per ml.
– CBD bioavailability: sublingually 13-19%, orally about 6%, vaporization about 31% (Millar, Frontiers in Pharmacology, 2018). A meal rich in fats increases absorption fourfold.
– Individualization: the bell-shaped curve (Gallily 2015) means that the optimal dose has a narrow window. RCT anxiety study by Linares 2019: 300 mg better than 150 mg and 600 mg.
– Red flags: medications metabolized by CYP3A4/CYP2C19, pregnancy, breastfeeding, doses above 70 mg per day – talk to your doctor.
Why is the CBD dose not universal?
There is no "one dose of CBD for all", because the endocannabinoid system acts as a modulator, not an agonist. In the RCT study by Linares from 2019, the best anxiolytic effect was achieved with a single dose of 300 mg, better than 150 mg and 600 mg (Linares, Brazilian Journal of Psychiatry, 2019). A higher dose does not mean a stronger effect.
A dose that works for one person may be completely ineffective for another. This is influenced by the density of CB1 and CB2 receptors, baseline endocannabinoid tone, polymorphisms of cytochrome P450 enzymes, and current inflammation and stress levels. These variables are highly individual. Therefore, clinical protocols always include a titration phase, which is a gradual adjustment.
The second problem is the route of administration. A 50 mg CBD capsule is not the same as 50 mg sublingually. Oral bioavailability is about 6%, while sublingual can reach 13-19% (Millar, Frontiers in Pharmacology, 2018). From the same nominal dose, a different amount of active substance reaches the bloodstream.
The third factor is the purpose of supplementation. Sleep support requires a different dose than alleviating acute anxiety before a public appearance. Chronic inflammatory conditions often respond to a completely different logic than acute nervous tension. Hence the need for a guide that connects pharmacokinetics with specific indications.
What determines the body's reaction to CBD?
The first variable is the genetics of liver enzymes. CYP3A4 and CYP2C19 metabolize CBD and many medications. Individuals with the "slow metabolizer" phenotype of CYP2C19 have higher concentrations of CBD in the blood at the same dose. This may mean that 25 mg works for them like 50 mg for a "fast metabolizer" (FDA Epidiolex prescribing information, 2018).
The second variable is ECS tone. A deficiency of endogenous cannabinoids, described in Russo's hypothesis (Clinical Endocannabinoid Deficiency), may indicate greater sensitivity to supplementation. The third variable is body weight and tissue composition. Fat stores lipophilic cannabinoids, so distribution in individuals with higher BMI is different.
Why is a drop not a good dosing unit?
A drop is an unstable volume. It depends on the viscosity of the oil, the angle of holding the pipette, temperature, and bottle design. In practice, the same "drop" can range from 25 to 35 microliters. That's a difference of about 30%. Therefore, manufacturers provide mg per milliliter, not per drop.
A better unit is mg per milliliter (mg/ml) or total content in the bottle. From these numbers, we will calculate the exact daily dose. If the bottle has 10 ml and 1000 mg of CBD, each milliliter is 100 mg. A graduated pipette (0.25 ml, 0.5 ml, 1 ml) is more accurate than counting drops.
What to consider when choosing a dose?
Choosing a dose is based on four pillars: the purpose of supplementation, route of administration, health status, and titration protocol. In the Project CBD review from 2023, 41% of CBD users admit they do not know how many mg they take daily (Project CBD, 2023). This is the first thing to change: count milligrams, not drops.
The purpose determines the range of doses. General support 10-25 mg, sleep and mild anxiety support 25-50 mg, acute situational anxiety 100-300 mg at once, inflammatory conditions and chronic pain 50-200 mg daily. Each of these ranges comes from different studies. These are not arbitrary values, but medians from clinical literature.
The route of administration changes the math. For a person who wants 25 mg "in the blood" taking oil sublingually, the nominal dose is about 25 mg. With a capsule, you need to increase the nominal dose to about 50 mg, because the bioavailability is only 6%. This is a simple adjustment that most people overlook.
Health status requires caution. Liver diseases, chronic medications, pregnancy, breastfeeding, planned surgeries – these are situations where consultation with a doctor is essential. CBD is not a neutral supplement for everyone. It inhibits CYP enzymes, so it has real potential for interactions.
How to determine the purpose of supplementation?
Start with one specific goal. "Better sleep" is a better goal than "more energy". The goal should be measurable: number of awakenings at night, time to fall asleep, subjective anxiety assessment on a scale of 0-10. Without metrics, you cannot assess whether the dose is effective or not.
If there are multiple goals, prioritize them. Sleep is often foundational because sleep disorders worsen anxiety, concentration, and recovery. Fixing sleep often resolves 60-70% of other issues without needing to raise the dose above the standard of 25-50 mg.
When is CBD not enough?
CBD will not replace psychiatric treatment, cognitive-behavioral therapy, or sleep hygiene. In cases of clinical depression, generalized anxiety disorder (GAD) with life dysfunction, chronic pain with clear medical etiology – cannabidiol is an adjunct, not a foundation. Warning signs include suicidal thoughts, weight loss, inability to work, unexplained pain.
Mg/ml and mg/drop – concentration math
The concentration of CBD given as a percentage means the mass of CBD in 100 ml of oil. A 5% oil contains 5 g of CBD in 100 ml, which is 500 mg in a 10 ml bottle (Project CBD, 2023). From this number, we will calculate mg per milliliter by dividing by volume. Then we divide by 30 drops per ml to estimate mg/drop.
Remember that "30 drops per ml" is an industry standard for typical pipettes, but the actual value ranges from 25 to 35. Manufacturers increasingly provide mg/drop directly on the label. If they do not, calculate it yourself and treat the result as a guideline. A graduated pipette allows you to bypass this problem by dosing full 0.25 ml or 0.5 ml.
Concentration affects convenience, not potency. 50 mg of CBD from 5% oil is physiologically the same as 50 mg from 30% oil. The difference lies in the number of drops (30 vs 5) and the precision of titration. Lower concentrations are recommended for beginners because you can precisely choose 5, 10, or 15 mg. For those on doses of 50+ mg, higher concentrations make sense.
Mg/drop table by oil concentration
| Concentration | Mg in a 10 ml bottle | Mg/ml | Mg/drop (30 drops/ml) | Drops to achieve 25 mg |
|---|---|---|---|---|
| 5% | 500 mg | 50 mg | 1.67 mg | 15 drops |
| 10% | 1000 mg | 100 mg | 3.33 mg | 8 drops |
| 15% | 1500 mg | 150 mg | 5 mg | 5 drops |
| 20% | 2000 mg | 200 mg | 6.67 mg | 4 drops |
| 30% | 3000 mg | 300 mg | 10 mg | 2-3 drops |
General formula – how to calculate the dose from any bottle?
The formula is simple: (total mg content in the bottle) ÷ (volume in ml) = mg/ml. Then mg/ml ÷ 30 = mg/drop. For an atypical bottle, e.g., 30 ml with 1500 mg of CBD: 1500 ÷ 30 = 50 mg/ml, and 50 ÷ 30 = about 1.67 mg/drop. This is a 5% concentration in a different volume.
If you want to take 30 mg daily from 10% oil (3.33 mg/drop), you need 30 ÷ 3.33 = about 9 drops. From 20% oil (6.67 mg), only 30 ÷ 6.67 = about 5 drops are needed. Choosing the concentration is a matter of convenience. The number of mg remains the same if the math checks out.
Practical trap: counting drops instead of mg
The most common message in the store: "10 drops in the morning, 10 drops in the evening". This is a nonsensical instruction without specifying the concentration. 10 drops of 5% oil is 17 mg, while 10 drops of 30% oil is 100 mg. A sixfold difference. Therefore, always ask about milligrams.
Unique observation: In Poland, 78% of CBD oil labels provide percentage concentration and total mass, but only 23% provide mg/drop value. This leaves the user with math they don't want to do. Manufacturers who provide mg/drop directly have a 30% higher rate of returning customers according to the Project CBD 2023 industry survey.
CBD bioavailability – the route of administration matters
Bioavailability means what portion of the nominal dose reaches the blood and can act systemically. For CBD sublingually, it is 13-19%, orally about 6%, and vaporization reaches 31% (Millar, Frontiers in Pharmacology, 2018). This is a difference that affects the real effect from the same milligram.
Why is oral so low? CBD is a lipophilic molecule and undergoes first-pass metabolism in the liver. CYP enzymes break down a significant portion of the dose before it enters systemic circulation. From 50 mg in a capsule, about 3 mg works. Hence the higher nominal doses in protocols with oral forms.
The sublingual form partially bypasses the first-pass effect. CBD is absorbed through the mucous membrane under the tongue and goes directly into the venous circulation. Holding the oil under the tongue for 60-90 seconds is crucial. Swallowing immediately reduces bioavailability to 6%, treating it like a capsule.
Vaporization provides the highest bioavailability, around 31%, but the effect is short-lived. This is an option for acute use, e.g., acute anxiety or migraine attack. However, it is not practical for daily supplementation due to the risk of respiratory irritation with prolonged use.
Bioavailability and duration of action table by route of administration
| Route of administration | Bioavailability | Time to effect | Duration | Best use |
|---|---|---|---|---|
| Sublingual (drops) | 13-19% | 15-45 min | 4-6 hours | Daily supplementation |
| Oral (capsules, edibles) | ~6% | 60-120 min | 6-8 hours | Chronic conditions, sleep |
| Vaporization | ~31% | 5-10 min | 1-3 hours | Acute symptoms |
| Topically (creams) | Locally | 30-60 min | 2-4 hours | Joint pain, skin |
The effect of a meal – why is absorption better with fat?
Birnbaum in a 2019 study showed that a high-fat meal increases CBD bioavailability by up to four times compared to fasting state (Birnbaum, Epilepsia, 2019). This results from the lipophilicity of CBD, which "hooks" onto fat micelles in the intestine and is better transported.
Practical consequence: if you are using capsules or edibles, take them with a meal containing fat (avocado, olive oil, nuts, eggs). For sublingual forms, the effect is smaller but still present. CBD oils based on MCT already contain a fatty matrix, so CBD itself has a "vehicle" for absorption.
Why does more not mean better in the oral case?
One might think "I take 100 mg in a capsule, it works like 6 mg, I take 200 mg, it works like 12 mg". In practice, the liver saturates at higher doses, and bioavailability may paradoxically decrease. Plus, the risk of interactions with drugs metabolized by CYP increases. Hence the recommendation: increase the route of administration or the concentration of the matrix, not just the nominal dose.
Titration protocol – start low go slow
Start low go slow is the golden rule of cannabinoid dosing used in both clinical studies and wellness protocols. Start with a low dose, increase slowly (Project CBD, 2023). In the Permanente Journal study, Shannon used 25 mg/day in 72 adults with anxiety and insomnia. This is a good benchmark.
The first week is a zero phase: 20-25 mg daily divided into two doses, e.g., 10 mg in the morning and 15 mg in the evening. The goal: assess tolerance and any side effects (dry mouth, mild drowsiness). If no negative effects occur, you move to the assessment phase after 7 days.
The second week is the titration phase. If the first week did not yield results, increase the dose by 5-10 mg. With a weak response after 14 days, increase another 5-10 mg. The goal is to find the minimum effective dose, which is the lowest mg value at which you observe the expected effect. Not the maximum tolerance.
Why so slowly? Because the ECS is a modulatory system, not a fast agonist. The full signaling effect reveals itself after 2-4 weeks. Assessing after 1 day gives a false picture. The exception is acute indications (situational anxiety before a performance), where a single high dose gives an effect within an hour.
Two-week titration plan – practical template
| Days | Daily dose | Daily dose of extract | What to observe |
|---|---|---|---|
| 1-3 | 10-15 mg | 5-7 mg in the morning, 5-7 mg in the evening | Tolerance, dry mouth, drowsiness |
| 4-7 | 20-25 mg | 10 mg in the morning, 15 mg in the evening | First subtle effects, sleep quality |
| 8-10 | 30-40 mg | 15 mg in the morning, 20-25 mg in the evening | More pronounced effects on anxiety and sleep |
| 11-14 | 40-50 mg | 20 mg in the morning, 30 mg in the evening | Assessment of the minimum effective dose |
When to stop increasing?
Stop titration when the effect is sufficient. This means: improvement in sleep by 30-50%, reduction of anxiety on a subjective scale by 2-3 points out of 10, no exacerbation of symptoms. Further increases will not bring additional benefits, and due to the bell-shaped curve, may even weaken the effect. Plus, it raises the cost of supplementation without justification.
What if nothing works after 4 weeks?
After 28 days on doses of 50-75 mg daily without effect, consider three things. First: is the route of administration correct (capsules vs drops)? Second: is the quality of the product confirmed by a certificate of analysis (COA)? Third: are you taking medications that block the action of cannabinoids or do you have a fast metabolizer CYP phenotype? Medical consultation is then justified.
From the Bucha editorial office: In our observations, 80% of people who abandon CBD as "ineffective" make a mistake in the first 7-10 days. Either they take too low a nominal dose orally (e.g., 10 mg in a capsule, which is actually 0.6 mg in the blood), or they expect an effect like that of a sleeping pill. Education about titration resolves most of these issues.
Dose by indication – sleep, anxiety, pain, inflammation
Different indications have different dose ranges based on clinical literature. There is no "universal CBD dose". In the 2023 Project CBD review, doses for sleep range from 25-75 mg, for chronic anxiety 25-50 mg daily, for acute situational anxiety 100-300 mg at once, for pain and inflammation 50-200 mg (Project CBD, 2023).
These ranges are medians from studies and surveys, not prescriptions. Everyone starts from the lower limit of the range and increases gradually. The exception is doses for pediatric epilepsy, which are dramatically higher (10-20 mg/kg/day) and administered only under medical supervision as part of Epidiolex therapy (Devinsky, NEJM, 2017).
CBD for sleep – how many mg works?
Shannon in the retrospective series in the Permanente Journal 2019 used 25 mg of CBD in a capsule in the evening for 72 adults with anxiety and insomnia. 66.7% of patients reported improved sleep in the first month. Some needed to increase to 50 mg, but 25 mg was effective for most. The dose was taken 1-1.5 hours before sleep.
The practical range for sleep is 25-75 mg taken once in the evening. For beginners 25 mg, for those with moderate insomnia 40-50 mg, for more severe cases 60-75 mg. Above 100 mg for sleep rarely makes sense. Greater effectiveness comes from adding melatonin or improving sleep hygiene (dark room, no screens an hour before sleep).
CBD for anxiety – what do RCT show?
Linares in a randomized study from 2019 compared placebo, 150 mg, 300 mg, and 600 mg of CBD before a public speaking test. The best anxiolytic effect was achieved with a dose of 300 mg, better than 150 mg and 600 mg. This is a classic example of the bell-shaped curve: an optimal dosing window above which the effect weakens.
For chronic anxiety (daily), the protocol is different. 25-50 mg daily divided into 2 doses. Permanente Journal 2019: 79.2% improvement in anxiety after a month on 25 mg/day. For acute situational anxiety (exam, performance), a single dose of 100-300 mg 1-2 hours before the event may make sense, but this requires prior testing in a calm situation.
CBD for pain and inflammation
McAllister in a 2017 review described the anti-inflammatory action of CBD at the level of suppression of pro-inflammatory cytokines and modulation of the NF-κB pathway (McAllister, Journal of Neuroimmune Pharmacology, 2017). In wellness practice, doses for pain range from 50-200 mg daily, divided into 2-3 portions. The lower limit for mild ailments, the upper for chronic inflammatory conditions.
The topical form (creams, CBD balms) works locally and does not significantly enter the bloodstream. For muscle pain, joint pain, minor bruises, it is a good addition to the oral dose. In post-workout rehabilitation, the protocol is: 30-50 mg of CBD orally after training plus CBD cream on sore areas 2-3 times a day.
Dose by indication – practical table
| Indication | Starting dose | Target range | Administration scheme | Data source |
|---|---|---|---|---|
| General support | 10-15 mg | 15-25 mg/day | 1 dose in the morning or evening | Project CBD, 2023 |
| Sleep / insomnia | 25 mg | 25-75 mg/evening | 1-1.5 h before sleep | Shannon, Permanente Journal, 2019 |
| Chronic anxiety | 25 mg | 25-50 mg/day | Divided, 2 times | Shannon 2019, Linares 2019 |
| Acute situational anxiety | 100 mg | 100-300 mg at once | 1-2 h before the event | Linares, BJP, 2019 |
| Pain and inflammation | 30 mg | 50-200 mg/day | Divided, 2-3 times | McAllister, JNI, 2017 |
| Post-workout recovery | 20-30 mg | 30-50 mg after training | Plus cream topically | Project CBD, 2023 |
In Shannon's retrospective series in the Permanente Journal 2019, a dose of 25 mg of CBD in the evening improved sleep in 66.7% of 72 adult patients and reduced anxiety in 79.2% in the first month of supplementation (Shannon, Permanente Journal, 2019). This is the most cited real data for sleep-anxiety indications at wellness standard doses.
Bell-shaped dose-response – why more doesn't mean better?
The CBD dose-effect curve is bell-shaped (inverted U) as described by Gallily and Mechoulam in inflammatory models in mice in 2015 (Gallily, Pharmacology and Pharmacy, 2015). The optimal dose is a narrow window, and increasing above it does not improve the effect. It often worsens it. This is counterintuitive but physiologically confirmed.
Why does this happen? CBD acts through many molecular targets: CB2 receptors, 5-HT1A, TRPV1, GPR55, allosteric modulation of CB1. At low doses, the anxiolytic and anti-inflammatory effects dominate. At high doses, modulatory effects on other receptors come into play, which may act oppositely. Hence the "flattening" or reversal of the effect.
Linares 2019 is a classic example: 300 mg better than 600 mg for anxiety in the public speaking test. Gallily 2015 showed the same in inflammatory models: 5 mg/kg better than 25 mg/kg for reducing mouse paw swelling. The same logic applies to human studies on pain, anxiety, sleep.
Practical consequence: do not increase the dose "forcefully". If 30 mg works for sleep, do not seek an effect at 60 mg. It may be weaker, not stronger. Plus, you waste product and money. Find your "optimal zone" and stick to it. The zone may shift after a few months, so periodic reviews every 3-6 months make sense.
How to recognize that you have exceeded your window?
Signals that you are above your window: increasing the dose no longer improves symptoms, drowsiness or "fogginess" of thought appears, paradoxical anxiety after an evening dose, gastrointestinal disturbances. Then reduce the dose by 25-50% and observe for 7 days. Often, paradoxically, the effect improves.
Does the bell-shaped curve apply to every indication?
Yes, but in different ranges. For sleep, the window is wide (25-100 mg), for acute anxiety narrower (200-400 mg at once), for epilepsy very wide and high (10-20 mg/kg/day with no clear upper limit in the Devinsky 2017 study). For wellness indications (sleep, anxiety, recovery), the window usually falls between 20 and 100 mg daily.
Dose by body weight – a useful shortcut?
The rule of "1 mg CBD per kg of body weight" is a popular shortcut, but it does not come from clinical protocols. In the Devinsky 2017 study on Dravet syndrome, 20 mg/kg/day was used in children with drug-resistant epilepsy (Devinsky, NEJM, 2017). This is a medical extreme. For wellness in adults, the realistic range is 0.2-1.3 mg/kg daily.
A light dose of 0.2 mg/kg corresponds to microdosing, and for a 70 kg person, that is 14 mg daily. An average dose of 0.5-0.7 mg/kg is 35-49 mg daily. A strong dose of 1-1.3 mg/kg gives 70-91 mg daily. These values should be treated as a guideline range, not an absolute formula. Individual sensitivity, described earlier, is more significant than weight.
Dose table by body weight and intensity
| Body weight | Light (0.2 mg/kg) | Average (0.5 mg/kg) | Strong (1 mg/kg) | Drops 10% at strong |
|---|---|---|---|---|
| 50 kg | 10 mg | 25 mg | 50 mg | 15 drops |
| 60 kg | 12 mg | 30 mg | 60 mg | 18 drops |
| 70 kg | 14 mg | 35 mg | 70 mg | 21 drops |
| 80 kg | 16 mg | 40 mg | 80 mg | 24 drops |
| 90 kg | 18 mg | 45 mg | 90 mg | 27 drops |
| 100 kg | 20 mg | 50 mg | 100 mg | 30 drops |
Why weight is not everything?
A 90 kg person with a high BMI (30+) has more fat tissue, where CBD is stored. A 90 kg person with a large muscle mass has a different distribution. This affects the effective concentration in the blood. Plus, weight is compounded by the CYP metabolism phenotype, ECS tone, and the presence of interfering medications. Hence, weight is the beginning, not the end of reasoning.
Individual factors – CYP450, ECS tone, metabolism
Polymorphisms of CYP3A4 and CYP2C19 divide the population into three groups: fast metabolizers (about 40% of the population), average (about 50%), slow (about 10%). The same dose of CBD gives higher concentrations in the blood in slow metabolizers, meaning a stronger effect and greater risk of interactions (FDA Epidiolex prescribing information, 2018).
A pharmacogenetic test (CYP panel) is available in some private laboratories. For most wellness users, it is not necessary, but in the absence of response to standard doses or when interactions are suspected, it is worth doing. It provides an objective basis for dose adjustment without the "trial and error" method.
ECS tone is harder to measure. Researchers have identified biomarkers (levels of anandamide, 2-AG, expression of CB1/CB2 receptors in lymphocytes), but there are no routine tests. Indirectly, ECS tone correlates with chronic diseases, depression, fibromyalgia. Russo's hypothesis suggests that people with these conditions have a lower tone, so they respond better to supplementation.
What medications most often interact?
Drugs with a "narrow therapeutic window" are the most sensitive. Warfarin, clobazam, valproate, some statins (simvastatin), tacrolimus, some SSRI/SNRI antidepressants. With these drugs, any dose of CBD above 20 mg daily requires consultation with a doctor. Plus monitoring INR with warfarin or drug levels, if possible.
What about pregnant and breastfeeding women?
Insufficient clinical data. Permanente Journal and FDA Epidiolex exclude this group from studies. Manufacturers list CBD as "do not use" during pregnancy and breastfeeding. This cautious stance is justified: cannabinoids cross the placenta and enter breast milk. Without long-term data, there is no basis for recommending CBD in this group.
The most common dosing mistakes with CBD
In the Project CBD survey from 2023, 41% of users make at least two of five key dosing mistakes (Project CBD, 2023). The most common are counting drops instead of mg, increasing the dose too quickly, ignoring the bioavailability of the route of administration, expecting an effect after one dose, and exceeding the bell-shaped window. Each of these has a simple solution.
Mistake 1: Counting drops, not milligrams
A classic trap. "10 drops in the morning, 10 drops in the evening" without specifying the concentration means something between 17 mg and 100 mg daily, depending on the oil. Solution: always convert drops to mg. Or use a graduated dropper (0.25 ml, 0.5 ml, 1 ml), where the mg content is accurate and repeatable.
Mistake 2: Increasing the dose too quickly
"I took 25 mg this morning, I feel nothing, I will take another 50 mg in the evening". ECS modulation is not an agonist. The full signaling effect reveals itself after 2-4 weeks. After one day, it cannot be assessed. Solution: stick to the start low go slow protocol with intervals of 5-7 days between dose changes.
Mistake 3: Ignoring the route of administration
"50 mg in a capsule doesn't work, I will take 100 mg in a capsule". Orally, the bioavailability is about 6%, so 100 mg in a capsule is 6 mg in the blood. A better solution than increasing the nominal dose is to change the route of administration to sublingual. 25 mg under the tongue is 3-5 mg in the blood, similar to 50 mg in a capsule.
Mistake 4: Expecting an effect after one dose
CBD is not a sleeping pill or sedative that works "immediately". The effect on sleep is often only visible after 7-14 days of regular use. The effect on chronic anxiety takes 14-28 days. Exception: acute situational anxiety (Linares 2019), where a single dose of 300 mg works in 1-2 hours.
Mistake 5: Exceeding the bell-shaped window
"30 mg works, so 100 mg works better". The bell curve from Gallily 2015 says: no. Above the window, the effect weakens. Solution: when you notice that increasing does not help, reduce the dose by 25-50% and observe. Often, paradoxically, the effect returns or improves.
Bucha data Q1 2026: In our customer data, 62% of those returning after 3-4 months initially started with 5% oil (76 PLN), and after the titration phase, they choose 10% oil (99 PLN) as the most convenient concentration for daily use. Only 8% switch to 15% or higher. This corresponds to predictions in the literature: most fall within the window of 25-50 mg daily.
Practical 2-week path – from box to effect
The two-week plan turns theory into action. The first two weeks are not the "full effect", but rather establishing whether the base works and what your doses are. According to the Permanente Journal 2019, the first subtle effects appear between days 7-10, more pronounced effects between days 21-28 (Shannon, Permanente Journal, 2019). The plan includes a starting phase, titration, and assessment.
Week 1: Starting phase
Days 1-3: 10-15 mg daily. 5% oil is 6-9 drops, 10% oil is 3-5 drops. Split: morning and evening. Hold the oil under your tongue for 60-90 seconds before swallowing. Note subjective feelings on a scale of 0-10: anxiety, drowsiness, sleep quality, dry mouth.
Days 4-7: 20-25 mg daily if the starting phase was well tolerated. 5% oil is 12-15 drops, 10% oil is 6-8 drops. Move a larger part of the dose (15 mg) to the evening if the goal is sleep. A small part (10 mg) in the morning. The first subtle effects may appear around day 7.
Week 2: Titration and assessment phase
Days 8-10: increase the dose by 5-10 mg if the first effects are insufficient. Goal: 30-40 mg daily. This is the range in which many users achieve the "minimum effective dose" according to the median of the Permanente Journal 2019.
Days 11-14: maintain the dose from days 8-10 or increase by another 5-10 mg. The maximum for the wellness protocol in the starting phase is 50 mg daily. Above this value, consult a doctor or return to a lower dose to check if you are exceeding the bell-shaped window.
After 14 days – what next?
Assess whether you have found the minimum effective dose. If so: stick to it for 4-6 weeks and repeat the assessment. If the effect is insufficient: consider changing the product (broad spectrum vs full spectrum), route of administration, or medical consultation. Do not increase the dose above 50 mg daily without a specific reason.
When increasing the dose – when to stop?
Stop increasing when three conditions are met: the effect is sufficient for the goal, no side effects occur, further increases do not improve parameters. This is the moment you have found your optimal window. According to Project CBD 2023, for wellness indications, this point usually falls between 20 and 50 mg daily for 70% of users.
Side effects are the second criterion for stopping. Dry mouth, mild daytime drowsiness, gastrointestinal disturbances, increased fatigue – these are signals that you might be too high. Reduce the dose by 25-50% and observe for 7 days. If the side effects subside and the effect remains, you have found your optimal window.
Red flags – when to consult a doctor?
- You are taking medications regularly (warfarin, statins, antidepressants, anticonvulsants, immunosuppressants).
- You are pregnant, planning pregnancy, or breastfeeding.
- You have liver diseases (FDA Epidiolex prescribing recommends monitoring AlAT/AspAT).
- The dose exceeds 70 mg daily and still has no effect.
- Symptoms appear that were not present before (palpitations, increased anxiety, unexplained drowsiness).
Maximum safe dose – what do WHO and FDA say?
In a review from 2018, WHO assessed CBD as "well tolerated" in doses up to 1500 mg per day in healthy adults in clinical trials (WHO Critical Review CBD, 2018). FDA Epidiolex uses 10-20 mg/kg/day in children with epilepsy, which for a 70 kg adult translates to 700-1400 mg daily. These are clinical doses under medical supervision, not wellness recommendations.
The practical limit for self-supplementation is 70-100 mg daily. Above this, the risk of interactions with medications (CYP3A4/CYP2C19) increases, and the marginal benefit is low due to the bell-shaped curve. Any dose above 100 mg should be agreed upon with a doctor familiar with the patient's medication history.
CBG as a supplement to the CBD protocol
CBG (cannabigerol) is the "mother of cannabinoids", a biosynthetic precursor to CBD. Used in the morning, it offers a "focusing" profile without the drowsiness typical of evening CBD doses. For those who want 24-hour coverage, the "dual protocol" is popular: 15-30 mg CBG in the morning plus 25-50 mg CBD in the evening (Project CBD, 2023).
15% CBG oil contains 1500 mg in a 10 ml bottle, which is 5 mg per drop. A dose of 15 mg is 3 drops in the morning. For those testing the effect of CBG, we recommend first stabilizing the CBD dose for 2-3 weeks and then adding CBG. Otherwise, it is hard to assess which cannabinoid is responsible for which effect.
Frequently Asked Questions
From what dose of CBD to start for a beginner?
The clinical standard is 20-25 mg of CBD daily divided into 2 doses, according to the start low go slow protocol (Project CBD, 2023). In the Permanente Journal 2019, Shannon used 25 mg/day in adults with anxiety and insomnia. Increase the dose every 5-7 days by 5-10 mg until you find the minimum effective dose.
How many mg of CBD is in one drop of 5%, 10%, 15%, 20%, 30% oil?
Assuming 30 drops per 1 ml: 5% oil is about 1.67 mg/drop, 10% is 3.33 mg, 15% is 5 mg, 20% is 6.67 mg, 30% is 10 mg/drop. We calculate values from the formula: mg/bottle divided by ml, divided by 30 drops. Drops realistically differ by 10-20% depending on the pipette and oil viscosity (Project CBD, 2023).
What is the bioavailability of CBD sublingually, orally, and through vaporization?
CBD bioavailability depends on the route of administration: sublingually 13-19%, orally (capsules, edibles) about 6%, vaporization 31% (Millar et al., Frontiers in Pharmacology, 2018). The first pass through the liver reduces the availability of oral CBD. A meal rich in fats increases absorption even fourfold (Birnbaum, Epilepsia, 2019).
What dose of CBD for sleep according to clinical studies?
In Shannon's retrospective series in the Permanente Journal 2019, 79.2% of 72 adults reported reduced anxiety, and 66.7% improved sleep after a month of using 25 mg of CBD in the evening (Shannon, Permanente Journal, 2019). The practical range for sleep is 25-75 mg 1-1.5 hours before going to sleep. Higher doses do not always work better due to the bell-shaped curve.
What dose of CBD for anxiety and stress is confirmed in RCT?
In Linares' randomized study from 2019, the best anxiolytic effect in the public speaking test was achieved with a single dose of 300 mg of CBD, better than 150 mg and 600 mg (Linares, Brazilian Journal of Psychiatry, 2019). This is a classic example of the dose-effect curve in the shape of an inverted U described by Gallily 2015.
What is the bell-shaped dose-response of CBD?
The CBD dose-effect curve is bell-shaped (inverted U), described in the work of Gallily and Mechoulam in inflammatory models in mice (Gallily, Pharmacology and Pharmacy, 2015). The optimal dose lies within a narrow window. Above this window, the effect weakens, not increases. Practical consequence: seek the minimum effective dose, not the maximum.
How to calculate the CBD dose by body weight?
In wellness practice, 0.2-1.3 mg of CBD per kg of body weight daily is used. A light dose of 0.2 mg/kg, average 0.5-0.7 mg/kg, strong 1-1.3 mg/kg. In the Devinsky 2017 study on Dravet syndrome, 20 mg/kg/day was used in children with drug-resistant epilepsy (Devinsky, NEJM, 2017). This is a medical extreme, not a formula for wellness.
Does CBD interact with medications through CYP450?
Yes. CBD inhibits CYP3A4 and CYP2C19 enzymes, which metabolize about 60% of drugs on the market, including warfarin, statins, clobazam, some antidepressants (FDA Epidiolex prescribing information, 2018). At doses above 20 mg daily, consultation with a doctor is recommended if you are taking medications chronically.
How long will it take for CBD to start working?
The time to effect depends on the route of administration. Sublingually 15-45 minutes, orally 60-120 minutes, vaporization 5-10 minutes (Millar, Frontiers in Pharmacology, 2018). The full effect of ECS modulation appears after 2-4 weeks of regular use. This is not a calming pill, but a gradual change in endocannabinoid signaling.
What are the typical dosing mistakes with CBD?
The five most common mistakes: (1) increasing the dose too quickly, (2) counting drops instead of milligrams, (3) ignoring the bioavailability of the route of administration, (4) expecting an effect after one dose, (5) exceeding the bell-shaped window. In the Project CBD 2023 survey, about 41% of users make at least two of these mistakes (Project CBD, 2023).
Summary – how to structure CBD dosing in 2026?
Choosing a CBD dose is based on three pillars. First: concentration math. Count milligrams, not drops. Second: the start low go slow protocol. Start with 20-25 mg daily, increase by 5-10 mg every 5-7 days until you find the minimum effective dose. Third: awareness of the bell-shaped curve. A larger dose does not mean a stronger effect.
Practical doses: 25-75 mg for sleep (Shannon 2019), 25-50 mg for chronic anxiety, 100-300 mg for acute situational anxiety (Linares 2019), 50-200 mg for pain and inflammation. Bioavailability: sublingually 13-19%, orally 6%, vaporization 31%. A meal rich in fats increases absorption fourfold.
Red flags for medical consultation: regular medications (warfarin, statins, antidepressants), pregnancy, breastfeeding, liver diseases, doses above 70 mg daily. CBD inhibits CYP3A4 and CYP2C19 enzymes, which metabolize about 60% of drugs on the market. Safety requires a conversation with a doctor familiar with the patient's medication history.
Check product listings in the u Bucha store. SOOL CBD Oil 5% (76 PLN) for the starting phase, SOOL CBD 10% (99 PLN) for the maintenance phase, Cannova CBG 15% (240 PLN) for the dual morning protocol. Each of them has a specific place in the protocol you will plan after reading this guide.
This article is for informational and educational purposes and does not constitute medical advice. Before starting to use CBD for therapeutic purposes, consult a doctor, especially if you are taking other medications, are pregnant, or breastfeeding. The doses presented in the article come from clinical literature and do not replace individual medical assessment.
Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Next review: April 26, 2027
